C. Aberham

发表

No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic

M. Farcet, T. Kreil, J. Schwaiger, 2020, The Journal of infectious diseases.

No SARS-CoV-2 cross-neutralization by intravenous immunoglobulins produced from plasma collected before the 2020 pandemic

M. Farcet, T. Kreil, J. Schwaiger, 2020, bioRxiv.

Spontaneous mutations in the human immunodeficiency virus type 1 gag gene that affect viral replication in the presence of cyclosporins

W. Phares, C. Aberham, S. Weber, 1996, Journal of virology.

Biological and Immunological Relations among Human Parvovirus B19 Genotypes 1 to 3

A. Ekman, M. Söderlund-Venermo, K. Hedman, 2007, Journal of Virology.

Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins

J. Modrof, A. Berting, T. Kreil, 2007, Transfusion.

A quantitative, internally controlled real-time PCR Assay for the detection of parvovirus B19 DNA.

M Gessner, P. Gross, C. Pendl, 2001, Journal of virological methods.

World Health Organization collaborative study to establish a replacement WHO international standard for hepatitis C virus RNA nucleic acid amplification technology assays

A. Heath, J. Saldanha, J. Albrecht, 2005, Vox sanguinis.

Intravirion Processing of the Human Immunodeficiency Virus Type 1 Vif Protein by the Viral Protease May Be Correlated with Vif Function

M. Khan, H. Akari, K. Strebel, 2002, Journal of Virology.

Human Immunodeficiency Virus Type 1 Vif Protein Is Packaged into the Nucleoprotein Complex through an Interaction with Viral Genomic RNA

R. Gorelick, M. Khan, H. Akari, 2001, Journal of Virology.

Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A

J. Luban, W. Phares, D. Braaten, 1996, Journal of virology.

Chicoric acid analogues as HIV-1 integrase inhibitors.

K. Kohn, Y. Pommier, E. De Clercq, 1999, Journal of medicinal chemistry.